Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

U.S. FDA approves Mirati's lung cancer drug

The U.S. Food and Drug Administration approved Mirati Therapeutics Inc's lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.

Reuters

The FDA Is Doing Something That Could Actually Cut Overdose Deaths

Naloxone could be available without a prescription by spring.

Reason

Whitehall graduate scheme members to vote on strike action

About 900 civil servants on fast stream being balloted, with 81% backing industrial action at consultative stage

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Commonly-used artificial sweetener linked to anxiety, reveals a study

Aspartame, an artificial sweetener included in approximately 5,000 diet goods and beverages, has been linked by Florida State University College of Medicine researchers to anxiety-like behaviour in mice. Read on for details:

Dynamite News

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

Why some Black women won’t or can’t quit hair relaxers – even as the dangers become clearer

Studies show the products may double the risk of uterine cancer, but tradition, societal pressure and personal taste create obstacles to change

The Guardian - US

Paxlovid has been free so far. Next year, sticker shock awaits

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

As flu season hits South Florida hard, drug shortages cause panic

FORT LAUDERDALE, Fla. — Harni Patel, pharmacist and owner of Tamarac Pharmacy, finds herself fielding calls daily from panicked parents of feverish children searching for everything from Children’s Tylenol to Amoxicillin to Tamiflu.

Tribune News Service

3 High-Yield Dividend Stocks With Upside Potential Right Now

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

StockNews.com

Wall Street Loves This 1 Strong Buy Stock Right Now

Wall Street looks bullish on Biogen’s (BIIB) prospects after the company’s success during the Phase 3 clinical trial of lecanemab. The drug could boost the company’s financials significantly as it could herald a new era for people with Alzheimer’s disease. Its bright growth prospects have earned it a Strong Buy…

StockNews.com

Commonly used sweetener found linked to anxious behaviour in mice

‘Extrapolation of findings to humans suggests aspartame consumption may produce neurobehavioral changes’

The Independent UK

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

WEKU

Omicron-fighting COVID vaccine authorized for kids as young as 6 months

The omicron-fighting COVID-19 vaccine is now approved for children ages 6 months and older, the U.S. Food and Drug Administration said Thursday.

Tribune News Service

Musk's company is on a killing spree

Around 1,500 lab animals have died in tests at Neuralink, Elon Musk's medical device implant company

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Is lecanemab the Alzheimer's drug that will finally make a difference?

The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.

WEKU

Juul settles more than 5,000 lawsuits over its vaping products

Juul Labs has reached settlements covering cases brought by about 10,000 plaintiffs related to its vaping products. Buffeted by lawsuits, Juul announced hundreds of layoffs last month.

Chicago Sun-Times

Over-the-counter hearing aids are here: everything you need to know

First made available in October for adults with mild to moderate hearing loss, they’re cheaper and easier to get. Here’s a guide to who can use them and how to get them.

StockNews.com

3 Stocks Insiders Are Buying up Right Now

Insider buying is considered a reliable indicator of a company’s prospects since insiders have the most up-to-date knowledge about the company’s inner workings and its outlook that could be unknown to analysts and investors. Insiders have been buying up shares of Coca-Cola (KO), Biogen (BIIB), and Pure Storage (PSTG) of…

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Much of the CDC is working remotely. That could make changing the agency difficult

ATLANTA — Earlier this year, top leadership at the Centers for Disease Control and Prevention began a monumental task: turning the sprawling, labyrinthine organization known for its highly specialized, academically focused scientific research into a sleek, flexible public health response agency primed to serve the American public. It’s an attempt…

The Independent UK

Juul reaches settlements covering more than 5,000 cases

Electronic cigarette maker Juul Labs has reached settlements covering more than 5,000 cases brought by about 10,000 plaintiffs related to its vaping products

Reason

Drug Shortages? Ham-Handed Pandemic Interventions Deserve Much of the Blame

You can’t turn lives and economies off and on without inflicting lingering harm.

The Independent UK

Speedier drug approvals hit slowdown as FDA faces scrutiny

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs

StockNews.com

3 Intriguing Stocks to Buy for the Santa Claus Rally

With festive spending keeping the economy resilient despite the threat of interest rate hikes, it could be wise to invest in Pfizer (PFE), Broadcom (AVGO), and Restaurants Brands International (QSR) to give your portfolios a touch of holiday spirit. Continue reading….

Reuters

Chile investigates hepatitis A-tainted raspberries recalled in U.S.

Chile's government launched an investigation on Tuesday after raspberries from a Chilean company were recalled in the United States due to hepatitis A contamination.

The Independent UK

Panel calls for stronger leadership of FDA food programs

A panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health

1 … 107 108 109 110

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

333 stories

AVGO

301 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.